Aileron Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge MA United States (2005)

Organization Overview

First Clinical Trial
2013
NCT01775358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Aileron Therapeutics